OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

Your search returned 9 results.
Search:

SKU Category Vector Description Price Delivery
SC327298 Human cDNA pCMV6-XL5 TNIK (untagged)-Human TRAF2 and NCK interacting kinase (TNIK) transcript variant 7 (10ug) NM_001161565.1 $2300 6-7 weeks
RC228663 Human ORF PS100001 TNIK (Myc-DDK-tagged)-Human TRAF2 and NCK interacting kinase (TNIK), transcript variant 7 $1840 6-7 weeks
RC228663L1 Human ORF PS100064 Lenti-ORF clone of TNIK (Myc-DDK-tagged)-Human TRAF2 and NCK interacting kinase (TNIK), transcript variant 7, (10ug) $2210 8-9 weeks
RC228663L2 Human ORF PS100071 Lenti-ORF clone of TNIK (mGFP-tagged)-Human TRAF2 and NCK interacting kinase (TNIK), transcript variant 7, (10ug) $2430 8-9 weeks
RG228663 Human ORF PS100010 TNIK (GFP-tagged) - Human TRAF2 and NCK interacting kinase (TNIK), transcript variant 7 $2020 6-7 weeks
TF320665 Human shRNA pRFP-C-RS KIAA0551 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector $498 In Stock
TG320665 Human shRNA pGFP-V-RS KIAA0551 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector $650 2 Weeks
TR320665 Human shRNA pRS KIAA0551 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector $650 2 Weeks
/ UTR pMirTarget 3`UTR clone of TRAF2 and NCK interacting kinase (TNIK) transcript variant 7 for miRNA target validation NM_001161565.1 $495 3-4 weeks
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title